1,472,629 Shares in Ryan Specialty Holdings, Inc. (NYSE:RYAN) Acquired by Raymond James Financial Inc.

Raymond James Financial Inc. bought a new position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,472,629 shares of the company’s stock, valued at approximately $94,484,000. Raymond James Financial Inc. owned 0.56% of Ryan Specialty at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Hollencrest Capital Management acquired a new stake in Ryan Specialty during the third quarter worth approximately $25,000. Assetmark Inc. acquired a new stake in Ryan Specialty in the third quarter valued at approximately $34,000. Principal Securities Inc. grew its stake in Ryan Specialty by 164.7% in the fourth quarter. Principal Securities Inc. now owns 667 shares of the company’s stock valued at $43,000 after acquiring an additional 415 shares during the period. Quarry LP grew its stake in Ryan Specialty by 109.3% in the third quarter. Quarry LP now owns 808 shares of the company’s stock valued at $54,000 after acquiring an additional 422 shares during the period. Finally, Loomis Sayles & Co. L P grew its stake in Ryan Specialty by 26.3% in the third quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company’s stock valued at $91,000 after acquiring an additional 286 shares during the period. Institutional investors and hedge funds own 84.82% of the company’s stock.

Insider Activity

In other news, Director Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock in a transaction on Friday, December 13th. The stock was sold at an average price of $67.39, for a total value of $2,358,650.00. Following the completion of the transaction, the director now directly owns 65,100 shares in the company, valued at approximately $4,387,089. The trade was a 34.97 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Over the last three months, insiders sold 316,451 shares of company stock worth $20,907,793. 11.10% of the stock is owned by corporate insiders.

Ryan Specialty Stock Performance

Shares of RYAN opened at $69.31 on Monday. The firm has a market cap of $18.15 billion, a PE ratio of 100.45, a PEG ratio of 1.19 and a beta of 0.71. The stock’s fifty day moving average price is $66.57 and its two-hundred day moving average price is $67.60. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. Ryan Specialty Holdings, Inc. has a 1 year low of $48.48 and a 1 year high of $75.97.

Ryan Specialty (NYSE:RYAN) last announced its quarterly earnings results on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.02). The company had revenue of $663.53 million during the quarter, compared to analysts’ expectations of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. On average, equities research analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th will be given a $0.12 dividend. The ex-dividend date is Tuesday, March 4th. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.11. This represents a $0.48 annualized dividend and a dividend yield of 0.69%. Ryan Specialty’s payout ratio is 69.57%.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. Morgan Stanley assumed coverage on Ryan Specialty in a research note on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price objective for the company. Royal Bank of Canada reduced their price objective on Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a research note on Friday, February 21st. UBS Group raised their price objective on Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th. Wells Fargo & Company raised their price objective on Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a research note on Friday, February 21st. Finally, Barclays lifted their target price on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research report on Thursday, November 21st. One analyst has rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $75.27.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.